Biotage AB (BIOT) - Financial and Strategic SWOT Analysis Review

Date: July 19, 2016
Pages: 52
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: B648B1863ACEN
Leaflet:

Download PDF Leaflet

Biotage AB (BIOT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Biotage AB (Biotage) is a biotechnology company. It provides solutions in the field of medicinal and analytical chemistry, peptide synthesis, separation, and purification. Its major products include microwave instruments such as Biotage Initrieator +, Biotage Initiator Classic, and Biotage Advancer; industrial resins such as Resna, and molecularly imprinted polymers (MIPs);sample preparation instruments such as Biotage Extrahera, Biotage Pressure, Biotage VacMaster 10 and 20, and RapidTrace among others; flash purification cartridges and systems; and reaction screening instruments. Biotage offers solutions to academic institutions, biotechnology and pharmaceutical companies. The company operates through offices in China, Japan, the UK and US and distributors around the world. Biotage is headquartered in Uppsala, Sweden.

Biotage AB Key Recent Developments

Jun 14, 2016: Biotage Achieves ISO 14001:2004 Certification
Apr 28, 2016: Biotage: Interim report January - March 2016
Apr 20, 2016: Validated Method for Analysis of Urinary Catecholamines
Feb 18, 2016: Optimum Results with the New Metal Scavenger Screening Kit from Biotage
Feb 11, 2016: Biotage: Year-end report for 2015

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

    Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

    Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

    Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

    Note: Some sections may be missing if data is unavailable for the company
  • SECTION 1 - ABOUT THE COMPANY

    Biotage AB - Key Facts
    Biotage AB - Key Employees
    Biotage AB - Key Employee Biographies
    Biotage AB - Major Products and Services
    Biotage AB - History
    Biotage AB - Locations And Subsidiaries
    Head Office
    Other Locations & Subsidiaries

    SECTION 2 – COMPANY ANALYSIS

    Biotage AB - Business Description
    Biotage AB - Corporate Strategy
    Biotage AB - SWOT Analysis
    SWOT Analysis - Overview
    Biotage AB - Strengths
    Strength - Research and Development Activities
    Strength - Established Presence Across Several Geographies
    Strength - Customer Base
    Biotage AB - Weaknesses
    Weakness - Product Discontinuation
    Biotage AB - Opportunities
    Opportunity - Growing Aged Population
    Opportunity - Organic Growth Drivers
    Opportunity - Growing Clinical Laboratory Testing Industry
    Biotage AB - Threats
    Threat - Competition and Technological Change
    Threat - Stringent Governmental Regulations
    Threat - Changing Diagnostic Market Conditions
    Biotage AB - Key Competitors

    SECTION 3 – COMPANY FINANCIAL RATIOS

    Financial Ratios - Capital Market Ratios
    Financial Ratios - Annual Ratios
    Performance Chart
    Financial Performance
    Financial Ratios - Interim Ratios
    Financial Ratios - Ratio Charts

    SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

    Biotage AB, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
    Biotage AB, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
    Biotage AB, Recent Deals Summary

    SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

    Jun 14, 2016: Biotage Achieves ISO 14001:2004 Certification
    Jun 07, 2016: New On-line SPE Cartridges from Biotage
    Apr 28, 2016: Biotage: Interim report January - March 2016
    Feb 11, 2016: Biotage: Year-end report for 2015
    Oct 30, 2015: Interim report for the period January - September 2015
    Oct 26, 2015: Biotage Introduces Isolera Assist, a New Simple to Use Flash Purification Interface
    Sep 21, 2015: Biotage and CEO Torben Jörgensen Have Agreed to Extend Period of Service
    Aug 13, 2015: Interim report January - June 2015
    Jun 16, 2015: Biotage Continued Success in Re-Examination Proceedings
    Mar 06, 2015: SLE Method for Detecting NBOMes in Oral Fluid

    SECTION 6 – APPENDIX

    Methodology
    Ratio Definitions
    About GlobalData
    Contact Us
    Disclaimer

    LIST OF TABLES

    Biotage AB, Key Facts
    Biotage AB, Key Employees
    Biotage AB, Key Employee Biographies
    Biotage AB, Major Products and Services
    Biotage AB, History
    Biotage AB, Other Locations
    Biotage AB, Subsidiaries
    Biotage AB, Key Competitors
    Biotage AB, Ratios based on current share price
    Biotage AB, Annual Ratios
    Biotage AB, Interim Ratios
    Biotage AB, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
    Biotage AB, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
    Biotage AB, Recent Deals Summary
    Currency Codes
    Capital Market Ratios
    Equity Ratios
    Profitability Ratios
    Cost Ratios
    Liquidity Ratios
    Leverage Ratios
    Efficiency Ratios

    LIST OF FIGURES

    Biotage AB, Performance Chart (2011 - 2015)
    Biotage AB, Ratio Charts
    Biotage AB, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
    Biotage AB, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
    Skip to top


    Ask Your Question

    Biotage AB (BIOT) - Financial and Strategic SWOT Analysis Review
    Company name*:
    Contact person*:
    Phone/fax*:
    Email*:
    Request invoice
    Your enquiry:
    Please click on a Check Box below to confirm you are not a robot: